TG THERAPEUTICS INC. - COMMON STOCK

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

10 4 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

08 4 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Two Publications Highlighting BRIUMVI in Medical Journals

07 4 2025 07:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

24 3 2025 10:29:34 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

21 3 2025 16:10:11 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

20 3 2025 09:57:38 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

19 3 2025 15:08:13 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

14 3 2025 12:51:58 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

10 3 2025 09:46:35 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

07 3 2025 14:46:14 提供 NetDania Notify

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting

07 3 2025 07:30:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

06 3 2025 11:21:26 提供 NetDania Notify

NetDania - New 12 months High: TG THERAPEUTICS INC. - COMMON STOCK

04 3 2025 10:46:23 提供 NetDania Notify

TG Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

03 3 2025 07:00:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Presentation of Data for BRIUMVI® in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

27 2 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics to Host Conference Call on Fourth Quarter and Full Year 2024 Financial Results and Business Update

26 2 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the Americas Committee for Treatment and Research in Multiple Sclerosis Annual Forum

18 2 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics Provides Preliminary Fourth Quarter and Full Year 2024 Net Revenue and 2025 Anticipated Development Milestones

14 1 2025 07:00:00 提供 Nasdaq GlobeNewswire

TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

09 1 2025 07:30:00 提供 Nasdaq GlobeNewswire

TG Therapeutics to Participate in the Evercore HealthCONx Conference

29 11 2024 08:00:00 提供 Nasdaq GlobeNewswire